pharmaphorum

MARCH 3, 2022

DarioHealth has beefed up its sales and marketing channels as well as its range of digital health products thanks to a $30 million strategic alliance with drugmaker Sanofi. In February it also agreed a deal to acquire Physimax Technologies, which develops computer vision systems for musculoskeletal screening and injury assessments.

Behavioural Health 91

Behavioural Health Sales Marketing Clinical Trials 91

pharmaphorum

JANUARY 26, 2021

There is an opportunity to address this at scale with digital tools and techniques, and expand support into just about any therapeutic area through the holistic integration of mental and behavioural health solutions that improve patient care. Consolidation of digital health platforms. As such, reps will need to be reskilled.

Clinical Trials 141

Clinical Trials Clinical Trials Sales Life Science 141

pharmaphorum

JULY 30, 2021

US telehealth group Amwell has agreed to buy two digital health specialists – SilverCloud Health and Conversa Health – as it looks to expand its services amid a boom in virtual healthcare delivery. billion merger to create a digital health giant with pro forma sales of $1.3

Behavioural Health 95

Behavioural Health Sales Production Marketing 95

pharmaphorum

OCTOBER 2, 2020

“Modia is designed to close the gap as it relates to the access and receipt of quality, evidence-based therapeutic interventions and behavioural health services for individuals with OUD who participate in outpatient treatment with MAT,” said Michael Sumner, Orexo’s chief medical officer.

Behavioural Health 98

Behavioural Health Production FDA Approval Pharma Production 98

pharmaphorum

APRIL 25, 2022

Aaron Gani, founder and CEO of BehaVR, and Krys Zaluski, director of business development, digital health at Sumitomo Dainippon Pharma, discuss their groundbreaking partnership to develop and commercialise digital therapeutics (DTx) products. . Gani started BehaVR in 2016 to create DTx for mental and behavioural health.

Behavioural Health 105

Behavioural Health Production Clinical Trials Clinical Trials 105

pharmaphorum

DECEMBER 16, 2022

Digital therapeutics company Cognoa, which focuses on paediatric behavioural health, announced the appointment of Dr Sharief Taraman as its new CEO. Optibrium, another software developer in the AI drug discovery space, has appointed Ian Smith as its new chief technology officer. McKinnell, Jr. to support the company’s growth.

Behavioural Health 52

Behavioural Health Reagent Gene Therapy Production 52